Simon Chowdhury

Summary

Affiliation: Guy's and St Thomas' NHS Foundation Trust
Country: UK

Publications

  1. pmc A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findings
    M Okera
    Department of Medical Oncology, Guy s and St Thomas NHS Foundation Trust, Great Maze Pond, London SE1 9RT, UK
    Br J Cancer 104:407-12. 2011
  2. doi request reprint Causes of death in men with prostate cancer: an analysis of 50,000 men from the Thames Cancer Registry
    Simon Chowdhury
    Department of Medical Oncology, Guy s Hospital, King s College London, London, UK
    BJU Int 112:182-9. 2013
  3. doi request reprint Neoadjuvant and adjuvant treatment of renal cell carcinoma
    Kiruthikah Thillai
    Department of Medical Oncology, Guy s Hospital, London, UK
    Expert Rev Anticancer Ther 12:765-76. 2012
  4. doi request reprint Bone metastases in germ cell tumours: lessons learnt from a large retrospective study
    Mariam Jamal-Hanjani
    Department of Medical Oncology, Guy s Hospital, London, UK
    BJU Int 112:176-81. 2013
  5. doi request reprint Cytoreductive nephrectomy: past, present and future
    Myria Galazi
    Department of Medical Oncology, Guy s Hospital, London, SE1 9RT, UK
    Expert Rev Anticancer Ther 14:271-7. 2014
  6. ncbi request reprint Advances in the treatment of metastatic prostate cancer
    Simon Chowdhury
    The Prostate Centre, London, UK
    Practitioner 257:15-8, 2. 2013
  7. doi request reprint Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma
    Laura Tookman
    Department of Medical Oncology, St Bartholomew s Hospital, West Smithfield, London, UK
    Acta Oncol 52:987-93. 2013
  8. doi request reprint The role of metastasectomy in renal cell carcinoma
    Eleni Josephides
    Department of Medical Oncology, Guy s Hospital, London, SE1 9RT, UK
    Expert Rev Anticancer Ther 13:1363-71. 2013

Collaborators

  • S Popat
  • Lars Holmberg
  • Peter Harper
  • Roger Kirby
  • David Robinson
  • Henrik Møller
  • Myria Galazi
  • Eleni Josephides
  • Mariam Jamal-Hanjani
  • Thomas Powles
  • Alejo Rodriguez-Vida
  • Laura Tookman
  • Wendy Ansell
  • Jonathan Shamash
  • Sarah Rudman
  • Kiruthikah Thillai
  • M Okera
  • Noan Minh Chau
  • Peter Wilson
  • Stephen Harland
  • Melissa Phillips
  • Anna Karpathakis
  • Timothy Oliver
  • Amy Kwan
  • Athena Matakidou
  • Sukaina Rashid
  • Naveed Sarwar
  • Aneta Suder
  • Danish Mazhar
  • Suzanne Allan
  • L Pickering
  • D Gilbert
  • S Chan
  • N Osuji
  • F Lofts
  • L Jones
  • U Dernede
  • H Sykes
  • C Oakley
  • J Larkin

Detail Information

Publications8

  1. pmc A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findings
    M Okera
    Department of Medical Oncology, Guy s and St Thomas NHS Foundation Trust, Great Maze Pond, London SE1 9RT, UK
    Br J Cancer 104:407-12. 2011
    ..Chemotherapy-induced febrile neutropenia is a medical emergency complicating the treatment of many cancer patients. It is associated with considerable morbidity and mortality, as well as impacting on healthcare resources...
  2. doi request reprint Causes of death in men with prostate cancer: an analysis of 50,000 men from the Thames Cancer Registry
    Simon Chowdhury
    Department of Medical Oncology, Guy s Hospital, King s College London, London, UK
    BJU Int 112:182-9. 2013
    ..To investigate causes of death in a UK cohort of patients with prostate cancer...
  3. doi request reprint Neoadjuvant and adjuvant treatment of renal cell carcinoma
    Kiruthikah Thillai
    Department of Medical Oncology, Guy s Hospital, London, UK
    Expert Rev Anticancer Ther 12:765-76. 2012
    ..This review summarizes the evidence for targeted treatment in both the neoadjuvant and adjuvant setting, and its use with cytoreductive nephrectomy...
  4. doi request reprint Bone metastases in germ cell tumours: lessons learnt from a large retrospective study
    Mariam Jamal-Hanjani
    Department of Medical Oncology, Guy s Hospital, London, UK
    BJU Int 112:176-81. 2013
    ..To determine the characteristics of patients with germ cell cancer and bone metastases...
  5. doi request reprint Cytoreductive nephrectomy: past, present and future
    Myria Galazi
    Department of Medical Oncology, Guy s Hospital, London, SE1 9RT, UK
    Expert Rev Anticancer Ther 14:271-7. 2014
    ..Until new evidence is available, CN is a reasonable approach in selected patients with a resectable primary tumor and good performance status. ..
  6. ncbi request reprint Advances in the treatment of metastatic prostate cancer
    Simon Chowdhury
    The Prostate Centre, London, UK
    Practitioner 257:15-8, 2. 2013
    ..g. in addition to ADT at first presentation of metastatic disease, where it is likely that greater benefits will be seen...
  7. doi request reprint Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma
    Laura Tookman
    Department of Medical Oncology, St Bartholomew s Hospital, West Smithfield, London, UK
    Acta Oncol 52:987-93. 2013
    ..We have therefore assessed the use of single agent carboplatin at a dose of AUC 10 in patients with good prognosis metastatic seminoma...
  8. doi request reprint The role of metastasectomy in renal cell carcinoma
    Eleni Josephides
    Department of Medical Oncology, Guy s Hospital, London, SE1 9RT, UK
    Expert Rev Anticancer Ther 13:1363-71. 2013
    ..Although the evidence supporting this approach is limited, we believe it is a reasonable option for certain patients. This review summarizes the evidence supporting this approach. ..